6-Week Keytruda Safe, Effective in Melanoma

]]>(MedPage Today) -- Giving the anti-PD-1 immune checkpoint inhibitor pembrolizumab (Keytruda) at a higher dose but less often was safe and effective in patients with unresectable or metastatic melanoma, interim data from KEYNOTE 555 showed.Among...